Marshall Urist

Marshall Urist

Corporate Officer/Principal at ROYALTY PHARMA PLC

Net worth: 229 M $ as of 2026-05-30

50 year
Finance
Consumer Services
Health Technology

Profile

Dr. Marshall Urist is a Vice President-Research & Investments at RP Management LLC, an Executive Vice President-Research & Investments at Royalty Pharma Plc and a Head of Research & Investments at Royalty Pharma Manager LLC.
Previously, Dr. Urist was an executive director and the senior biotechnology analyst at Morgan Stanley.
He has a BA, Phi Beta Kappa, from Johns Hopkins University, a PhD from Columbia University and an MD from Columbia University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-05 2,474,120 ( 1.03% ) 138 M $ 2026-05-30
2026-04-05 1,356,528 ( 5.53% ) 76 M $ 2026-05-30
0.12%
2025-11-06 247,412 ( 0.12% ) 14 M $ 2026-05-30
2026-05-19 37,217 ( 0.01% ) 2 M $ 2026-05-30

Marshall Urist active positions

CompaniesPositionStart
ROYALTY PHARMA PLC Corporate Officer/Principal 2012-12-31
Corporate Officer/Principal 2013-07-18

Former positions of Marshall Urist

CompaniesPositionEnd
Analyst-Equity 2013-06-30
Analyst-Equity 2006-01-30
See the detail of Marshall Urist's experience

Training of Marshall Urist

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Finance

Finance

Consumer Services

Consumer Services

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. Marshall Urist
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!